Updated hourlyHourly refreshThu, Oct 8, 2026
Press Release Database
Recent press releases, indexed by topic.
In the wire
(PR-inside.com) Newport Beach surgeon is one of only 34 plastic surgeons nationwide selected in all six categories, out of more than 6,000 board-certified plastic surgeons evaluated. NEWPORT BEACH, CA / ACCESS Newswire / October 7, 2026 / Dr. Sanjay Grover, MD, FACS, a board-certified plastic surgeon and founder of Grover Aesthetics in Newport Beach, has been named to Newsweek's 2026 list of America's Best Plastic Surgeons, marking his sixth consecutive year of national recognition. Dr. Grover was honored in all six categories evaluated: Facelift, Eyelid Surgery, Rhinoplasty, Breast Augmentation, Tummy Tuck, and Liposuction. Within those six, he placed among the top 30 ..
Oct 7 · 19:00·PR-Inside
In the wire
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 7, 2026 / SMX has redefined what "Made in America" can mean in a global economy where origin claims, supply chains, materials, and compliance standards are under more scrutiny than ever. For decades, "Made in America" has been treated largely as a label. A patriotic phrase. A marketing advantage. A promise printed on packaging, stamped into metal, or attached to a finished product. But in today's industrial economy, a claim is no longer enough. Manufacturers, regulators, customers, and trading partners increasingly want proof. That is where SMX changes the equation. SMX's molecular marking and ..
Oct 7 · 19:00·PR-Inside
In the wire
Newport Beach surgeon is one of only 34 plastic surgeons nationwide selected in all six categories, out of more than 6,000 board-certified plastic surgeons evaluated.
Oct 7 · 19:00·Newswire.com
Finance
New York, New York--(Newsfile Corp. - October 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Innventure, Inc. ("Innventure" or the "Company") (NASDAQ: INV) on behalf of investors that purchased or otherwise acquired Innventure securities between November 17, 2025 and August 13, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Innventure and have suffered losses, you may CLICK HERE to contact us. You may also...
Oct 7 · 19:00·mlpr-newsfile
Finance
McConnell Labs rebrands, acquires ATTAIN Cosmetics, and brings a former customer and brand founder into leadership of the company behind Light Elegance. REDMOND, Ore., Oct. 7, 2026 /PRNewswire-PRWeb/ -- McConnell Labs, an American contract development and manufacturing organization...
Oct 7 · 19:00·PRWeb
In the wire
The Laser Agent identifies the Certified Pre-Owned laser systems attracting strong buyer interest as practices prioritize hair removal, skin rejuvenation, pigmentation, vascular treatments, tattoo removal, and resurfacing NOBLESVILLE, Ind., Oct. 7, 2026 /PRNewswire-PRWeb/ -- Which...
Oct 7 · 19:00·PRWeb
Finance
SPV, CERO 1236, to raise capital directly into subsidiary and not dilute existing SRX Global shareholders
Oct 7 · 19:00·GlobeNewswire
Finance · Healthcare
LOS ANGELES, CA - October 7, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) , a developer of next-generation antibody-based cancer therapies, provided an update on its strategy to implement U.S. Food and Drug Administration “FDA”-aligned New Approach Methodologies “NAMs” across its preclinical research and development programs. The company said the approach could accelerate clinical advancement, reduce development costs and timelines and significantly reduce animal testing. VERAXA has built a panel of NAMs to characterize and de-risk its pipeline of BiTAC-based T cell engagers, antibody-drug conjugates and bispecific antibody-drug conjugates. VERAXA said its lead BiTAC-TCE and bsADC candidates were also evaluated using an ex vivo panel of 10 low-passage patient-derived xenograft mod
Oct 7 · 18:58·NewMediaWire
Finance
New York, New York--(Newsfile Corp. - October 7, 2026) - Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) between May 19, 2026 and July 16, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 1, 2026.So what: If you purchased Alphabet securities during...
Oct 7 · 18:58·mlpr-newsfile
Finance
NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Simply Good Foods Company (NASDAQ: SMPL) between October 24, 2024 and April 8, 2026, inclusive (the "Class Period"), of the important October 13, 2026...
Oct 7 · 18:58·PR Newswire
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 7, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Doximity, Inc. (NYSE:DOCS) securities. If you suffered a loss on your Doximity, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Doximity, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Doximity, Inc. ..
Oct 7 · 18:57·PR-Inside
In the wire
Frøya, 7 October 2026
Oct 7 · 18:56·GlobeNewswire